NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)
This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.
This is a forecasted (not yet open) National Institutes of Health opportunity (NINDS) for efficacy and exploratory clinical trials using the UG3/UH3 phased award mechanism, with a clinical trial re…
- Deadline
- Not specified
- Posted
- Aug 28, 2025
- Award amount
- Amount not specified
In plain English
This is a forecasted (not yet open) National Institutes of Health opportunity (NINDS) for efficacy and exploratory clinical trials using the UG3/UH3 phased award mechanism, with a clinical trial required. Eligibility, award amount, and deadline are not yet published; awards of this kind go to research institutions able to run clinical trials, not individuals. Review the full notice before planning an application.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants from National Institutes of Health — soonest deadline first.
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
National Institutes of Health · Amount varies · Closed
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 3 days
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health · Up to $1M · Due in 3 days
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health · Amount varies · Due in 5 days
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 8 days
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
National Institutes of Health · Up to $250K · Due in 8 days
Also listed under National Institutes of Health.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.